OmniAb, Inc.
NASDAQ:OABI
3.94 (USD) • At close October 29, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | OmniAb, Inc. |
Symbool | OABI |
Munteenheid | USD |
Prijs | 3.94 |
Beurswaarde | 461,476,617 |
Dividendpercentage | 0% |
52-weken bereik | 3.56 - 6.715 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Matthew W. Foehr |
Website | https://www.omniab.com |
An error occurred while fetching data.
Over OmniAb, Inc.
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)